跳至主要内容
临床试验/NCT00372294
NCT00372294Unknown3 期

To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2005年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
试验地点
1

研究概览

简要总结

Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin & Dexamethasone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with Toxoplasmic chorioretinitis
  • Location of the lesion within zone I of the retina or a lesion greater than 2DD with 3+-4+ vitreous inflammation in zone II or III
  • No allergic history to the used drugs
  • No any other diseases

排除标准

  • Any allergic reaction to the used medications
  • One eyed patients
  • Partially treated patients

研究组 & 干预措施

1

Active Comparator

Classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon)

干预措施: pyrimethamine-sulfadiazine + prednisolone (Drug)

2

Active Comparator

Intravitreal Clindamycin & Dexamethasone

干预措施: Clindamycin+Dexamethasone (Drug)

研究者

研究点 (1)

Loading locations...

相似试验

To Compare Intravitreal Clindamycin & Dexamethasone... | 临床试验